Tempest Therapeutics, Inc.
TPST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $303 | $68 | $13 | $2 |
| - Cash | $30 | $39 | $31 | $52 |
| + Debt | $15 | $21 | $22 | $19 |
| Enterprise Value | $288 | $49 | $4 | -$32 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$40 | -$28 | -$33 | -$27 |
| % Margin | – | – | – | – |
| Net Income | -$42 | -$29 | -$36 | -$28 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.5 | -1.91 | -3.18 | -7.8 |
| % Growth | 21.5% | 39.9% | 59.2% | – |
| Operating Cash Flow | -$33 | -$27 | -$31 | -$26 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$33 | -$28 | -$32 | -$26 |